CRU-GLOBAL is a Clinical Research Site Network with sites and offices in Europe and South-East Asia conducting studies from Phase I-IV for sponsors at CRU owned facilities which include CRU’s Early Phase Units in Miskolc city (Hungary), in Khust city (Ukraine) and Hanoi city (Vietnam).
Due to the increasing need from our study sponsors – especially in early phase studies – CRU-GLOBAL developed its own CRO department and services for pharmaceutical and MedTech industry. CRU-GLOBAL is able to conduct all study related activities with its own permanent staff, and in very special cases with CRU-GLOBAL’s regular external consultants.
It was established in 2016, based on the initial idea of dr. Péter Kovács – CEO of CRU Hungary Ltd., to lead the national efforts in biomarker research, provide a service both for the clinical and the pharmaceutical industry, as well as for the national healthcare system and for the wider public.
